Equine CA50 antibody and antigen (recombinant protein)
Diagnostic anti-Equine CA50 antibodies pairs and antigen for animal health (animal Equine/Horse pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-CA50-Ag01 | Recombinant Equine CA50 protein | 3090 |
GMP-EQU-CA50-Ab01 | Anti-Equine CA50 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-CA50-Ab02 | Anti-Equine CA50 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-CA50-Ab03 | Anti-Equine CA50 human monoclonal antibody (mAb) | 1953 |
GMP-EQU-CA50-Ab04 | Anti-Equine CA50 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-CA50-Ag01 |
Product Name | Recombinant Equine CA50 protein |
Target/Biomarker | Equine Carbohydrate Antigen 50 (AIV-A N3 subtype) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine Carbohydrate Antigen 50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AIV-A N3 subtype level test of animal Equine/Horse with pancreatic and colorectal cancer. |
Tag | His |
Products description | Recombinant Equine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CA50-Ab01, GMP-EQU-CA50-Ab02 |
Product Name | Anti-Equine CA50 mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine Carbohydrate Antigen 50 (AIV-A N3 subtype) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine Carbohydrate Antigen 50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N3 subtype antibodies in AIV-A N3 subtype level test of animal Equine/Horse with pancreatic and colorectal cancer. |
Tag | mFc |
Products description | Anti-Equine CA50 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N3 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CA50-Ab03, GMP-EQU-CA50-Ab04 |
Product Name | Anti-Equine CA50 human monoclonal antibody (mAb) |
Target/Biomarker | Equine Carbohydrate Antigen 50 (AIV-A N3 subtype) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine Carbohydrate Antigen 50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N3 subtype antibodies in AIV-A N3 subtype level test of animal Equine/Horse with pancreatic and colorectal cancer. |
Tag | hFc |
Products description | Anti-Equine CA50 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-AIV-A N3 subtype antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in equine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in horses, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of equine health, elevated levels of CA50 in a horse's bloodstream can serve as a crucial indicator of the presence of specific cancers. The production and release of CA50 by cancer cells, especially those found in gastrointestinal and pancreatic cancers, lead to increased concentrations of this glycoprotein in the blood.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.